The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
Year: 2020
Type: article
Abstract: The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT's scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed.
Source: Bone Marrow Transplantation
Authors: for the European Society for Blood and Marrow Transplantation, Per Ljungman, Malgorzata Mikulska, Rafael de la Camara, Grzegorz W. Basak, Christian Chabannon, Selim Corbacioglu, Rafael Duarte, Harry Dolstra, Arjan C. Lankester, Mohamad Mohty, Silvia Montoto, John Murray, Régis Peffault de Latour, John A. Snowden, Ibrahim Yakoub-Agha, Bregje Verhoeven, Nicolaus Kröger, Jan Styczynski
Institutions: Karolinska Institutet, Karolinska University Hospital, Ospedale Policlinico San Martino, University of Genoa, Hospital Universitario de La Princesa, Medical University of Warsaw, Inserm, Institut Paoli-Calmettes, University of Regensburg, Hospital Universitario Puerta de Hierro Majadahonda, Radboud University Medical Center, Leiden University Medical Center, Willem-Alexander Kinderziekenhuis, Hôpital Saint-Antoine, St Bartholomew's Hospital, Barts Health NHS Trust, The Christie NHS Foundation Trust, Hôpital Saint-Louis, Sheffield Teaching Hospitals NHS Foundation Trust, Université de Lille, Centre Hospitalier Universitaire de Lille, University Medical Center Hamburg-Eppendorf, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,860
OpenAlex ID: W3025499341
